ETHICS STATEMENT
All participants completed and signed an informed consent form prior to completing the in‐clinic point‐of‐care (POC) HbA1c test. If enrolled in the study, participants then completed and signed a second consent. This pilot study was approved by the IRB of the University of Florida, IRB # IRB201902145.